InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Explore the complete record of transactions filed by Valliant John, Chairman & CEO. Director active across 1 companies, notably Fusion Pharmaceuticals Inc.. Cumulatively, 17 reports have been published. Total volume traded: €388k. The latest transaction was filed on 25 April 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations17 total
€11,4592,036 shares@ €5.6283.0% of flow
Common Stock
SEC:0001209191-22-025783:0·
€2,036367 shares@ €5.54850.5% of flow
Common Stock
SEC:0001209191-22-025469:0·
€17,6152,600 shares@ €6.77524.5% of flow
Common Stock
SEC:0001209191-22-024330:0·
€696100 shares@ €6.95530.2% of flow
Common Stock
SEC:0001209191-22-023861:0·
€6,9991,000 shares@ €6.99941.8% of flow
Common Stock
SEC:0001209191-22-023124:0·
€2,021300 shares@ €6.73720.5% of flow
Common Stock
SEC:0001209191-22-022034:0·
€3,370500 shares@ €6.73960.9% of flow
Common Stock
SEC:0001209191-22-021487:0·
€27,3394,000 shares@ €6.83487.0% of flow
Common Stock
SEC:0001209191-22-020948:0·
€6,132900 shares@ €6.81371.6% of flow
Common Stock
SEC:0001209191-22-020316:0·
€8,2771,300 shares@ €6.36662.1% of flow
Common Stock
SEC:0001209191-22-019224:0·
€5,235822 shares@ €6.3681.3% of flow
Common Stock
SEC:0001209191-22-018455:0·
€55,5618,400 shares@ €6.614414.3% of flow
Common Stock
SEC:0001209191-22-017150:0·
€5,566847 shares@ €6.5711.4% of flow
Common Stock
SEC:0001209191-22-015555:0·
€16,3862,500 shares@ €6.55424.2% of flow
Common Stock
SEC:0001209191-22-013791:0·
€33,9564,898 shares@ €6.93278.7% of flow
Common Stock
SEC:0001209191-22-012344:0·
€92,83112,600 shares@ €7.367623.9% of flow
Common Stock
SEC:0001209191-22-010918:0·
€92,83112,600 shares@ €7.3676100.0% of flow
Common Stock
SEC:0001209191-22-010918·
17 of 17 declarations
About Valliant John
Valliant John is an insider at Fusion Pharmaceuticals Inc.
